Collegium Pharmaceutical COLL
NASDAQ COLL
$23.35 -0.02 (-0.06%)
As of: Sep 9, 2026 · 3:59 PM EDT

Collegium Pharmaceutical (COLL) Amortizatization of Intangibles (2018 - 2026)

Collegium Pharmaceutical (COLL) posted Amortizatization of Intangibles of $45000.0 for Q2 2026, down 74.72% on a QoQ basis from $178000.0 in Q1 2026, and down 82.95% year-over-year from $264000.0 in Q2 2025.

Analysis

Collegium Pharmaceutical (COLL) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends

Collegium Pharmaceutical has reported Amortizatization of Intangibles for 5 years, with the latest figure at $45000.0 in Q2 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 82.95% year-over-year to $45000.0 in Q2 2026; TTM through Jun 2026 was $707000.0, a 52.17% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 47.14% from the prior year.
  • Amortizatization of Intangibles was $45000.0 for Q2 2026 at Collegium Pharmaceutical, down from $178000.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $723000.0 in Q2 2024, with the low at $45000.0 in Q2 2026.
  • Average Amortizatization of Intangibles over 4 years is $371666.7, with a median of $350000.0 recorded in 2024.
  • The sharpest annual moves came in 2024 and 2026: Amortizatization of Intangibles declined 9.67% in 2024, then sank 82.95% in 2026.
  • Over 4 years, Amortizatization of Intangibles stood at $568000.0 in 2023, then tumbled by 33.8% to $376000.0 in 2024, then sank by 32.45% to $254000.0 in 2025, then plunged by 82.28% to $45000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $45000.0 (Q2 2026), $178000.0 (Q1 2026), and $254000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn -
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 984.00 Mn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn -
7 Revolution Medicines 43.79 Bn 43.79 Bn - 4.33 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn -
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn -
10 Collegium Pharmaceutical 753.09 Mn 603.77 Mn 110.29 Mn 45,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 45,000.00
Mar 31, 2026 178,000.00
Dec 31, 2025 254,000.00
Sep 30, 2025 230,000.00
Jun 30, 2025 264,000.00
Mar 31, 2025 324,000.00
Dec 31, 2024 376,000.00
Sep 30, 2024 514,000.00
Jun 30, 2024 723,000.00
Mar 31, 2024 415,000.00
Dec 31, 2023 568,000.00
Sep 30, 2023 569,000.00
Mar 31, 2018 29.53 Mn